According to FutureWise analysis the market for biosimilar interleukins in 2023 is US$ 2.83 billion, and is expected to reach US$ 44.48 billion by 2031 at a CAGR of 41.10%. The global market for Biosimilar Interleukin is on an exciting upward trajectory, poised for explosive growth. Starting at approximately USD 3.9 billion in 2023, it’s set to leap to USD 5.41 billion by 2024 and is...